David J. Kerr

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

Hans‐Joachim Schmoll, Eric Van Cutsem, Alexander Stein et al. · Annals of Oncology · 2012 · 1.5K citations · Full text

Medicine, Oncology, Surgery +17

Deep learning for prediction of colorectal cancer outcome: a discovery and validation study

Ole-Johan Skrede, Sepp de Raedt, Andreas Kleppe et al. · The Lancet · 2020 · 620 citations · Full text

Computing, Computer Science, Oncology +14

Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer

Sarah Danson, D. Ferry, Valery Yu. Alakhov et al. · British Journal of Cancer · 2004 · 377 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Wortmannin and Its Structural Analogue Demethoxyviridin Inhibit Stimulated Phospholipase A2 Activity in Swiss 3T3 Cells

Michael Cross, Allison Stewart, Matthew N. Hodgkin et al. · Journal of Biological Chemistry · 1995 · 250 citations · Full text

Life Sciences, Biochemistry, Pharmacology +4

Randomized, Placebo-Controlled, Phase III Study of First-Line Oxaliplatin-Based Chemotherapy Plus PTK787/ZK 222584, an Oral Vascular Endothelial Growth Factor Receptor Inhibitor, in Patients With Metastatic Colorectal Adenocarcinoma

J. Randolph Hecht, Tanja Trarbach, John D. Hainsworth et al. · Journal of Clinical Oncology · 2011 · 175 citations

Medicine, Oncology, Pharmacology +14